Korean J Med.
2019 Feb;94(1):57-82. 10.3904/kjm.2019.94.1.57.
2018 Korean Heart Rhythm Society Guidelines for Non-Vitamin K Antagonist Oral Anticoagulants
- Affiliations
-
- 1Division of Cardiology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
- 2Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Korea. mdhwp@chol.com
- 3Division of Cardiology, Department of Internal Medicine, KyungHee University Hospital, Seou, Korea.l.
- 4Division of Cardiology, Department of Internal Medicine, Hanyang University Seoul Hospital, Seoul, Korea.
- 5Division of Cardiology, Department of Internal Medicine, Daegu Catholic University College of Medicine, Daeg, Korea.
- 6Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Seoul, Korea.
- KMID: 2438028
- DOI: http://doi.org/10.3904/kjm.2019.94.1.57
Abstract
- Non-vitamin K antagonist oral anticoagulants (NOACs) are an alternative to vitamin K antagonists (VKAs) and have emerged as the treatment of choice in Korea. However, several questions remain regarding the optimal use of these agents in specific clinical situations. In this paper we discuss 1) patients with atrial fibrillation (AF) and coronary artery disease, 2) avoiding confusion with NOAC dosing across indications, 3) cardioversion in a patient treated with a NOAC, 4) AF patients who present with acute stroke while on NOACs, 5) NOACs in special situations, 6) anticoagulation in AF patients with a malignancy, and 7) optimizing VKA dose adjustments.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Adaptation of New Oral Anticoagulants for Warfarin Anticoagulated Patient with Traumatic Ongoing Hemorrhage
- 2018 KHRS Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Korean Patients with Atrial Fibrillation: How to Initiate and Organize the Follow-up
- The 2018 Korean Heart Rhythm Society Practical Guidelines on the use of Non-Vitamin K-Antagonist Oral Anticoagulants: Bleeding Control and Perioperative Management
- Non‑vitamin K antagonist oral anticoagulants in adults with congenital heart disease
- New oral anticoagulants
